PCM
MNTA

Pentwater Capital Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Pentwater Capital Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,348,200
Closed -$123M – 301
2020
Q3 		$123M Buy
+2,348,200
New +$97.2M 1.59% 14

Pentwater Capital Management's MNTA Position: Q4 2020 in Review

Pentwater Capital Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 2,348,200 shares — an estimated $123M sold.

Pentwater Capital Management first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $123M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Pentwater Capital Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Pentwater Capital Management sold 2,348,200 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $123M.
  • Pentwater Capital Management first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • Pentwater Capital Management's Momenta Pharmaceuticals, Inc. position peaked at $123M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Pentwater Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.